Pharma firm Venus Remedies today said it has bagged a contract from Thailand for an anti-cancer drug, Docetaxel, under the government policy.The company has received the contract from Government Pharmaceutical Organisation (GPO) under the Ministry of Health, Thailand, for supplying Docetaxel for one year as per the Thai government's strategy of providing quality product at an affordable prices, Venus Remedies said in a filing to the Bombay Stock Exchange (BSE)."The contract is valid for one year and is expected to generate a business of more than Rs 10 crore to the company," it said.
Total pharma market in Thailand is about $2.9 billion. Venus already has 10 product registrations in Thailand for oncology and anti-infective segments.
The Indian firm has bagged the contract through the compulsory license scheme by the Government Pharmaceutical Organisation (GPO). The GPO after importing the drug will make it available to the poor, who cannot afford high cost patented drugs.
Subscribe to:
Post Comments (Atom)
Superhit News
-
US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing fac... -
Goods and Service Tax (GST) is high on the agenda for the new government and its rollout is a priority. GST will benefit the Indian pharma... -
Rib-X Pharmaceuticals, Inc. announced today the signature of an exclusive worldwide research collaboration agreement and option for license ...
-
Physiomics: Reports difficult trading but highlights growing interest from big pharmaceutical groupsPhysiomics ( LON:PYC ) said that trading conditions were difficult in the six months ended 31 December 2010, but it believes it is in a be...
-
Hindusthan National Glass and Industries Ltd is expected to finalize a strategic overseas acquisition in the pharmaceuticals space in the n...
-
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about th... -
The government is hoping to see the implementation of the track and trace system for domestic and export supply chain in another one y... -
India's Central Drugs Standard Control Organization (CDSCO) has suspended the manufacturing of eye drops at the Chennai-based firm after... -
Diclofenac injection is a painkiller which is manufactured by Themis Medicare Ltd and marketed by Novartis India under the brand name ... -
Amylin Pharmaceuticals, Inc. AMLN +16.15% and Alkermes plc ALKS +4.61% today announced that the U.S. Food and Drug Administration (FDA) has ...
No comments:
Post a Comment